Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that ...

Atopic dermatitis, characterised by persistent itch and recurrent skin lesions, affects up to 1.6 million people in the UK, while prurigo nodularis, which causes intense itch and thick skin nodules, ...

Eczema is a chronic (long-term) disease that causes dry, itchy skin. It usually comes and goes, and when it's active, it's called a flare-up or flare. A flare-up usually occurs in response to a ...

Dermatitis is a term that means inflammation of the skin. Eczema is a term used to describe a group of chronic skin conditions that cause itchy, dry, and inflamed skin. People often use the terms ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

Sweat is a common trigger for people with eczema. It can dry out the skin, and various substances in sweat may irritate skin with eczema and worsen symptoms. Sweat has natural moisturizing ...

Learn more Redness, dryness, scaly patches, and itchy rashes — these are just a few of the not-so-fun symptoms of eczema, also known as atopic dermatitis. It's a pretty common condition ...

Sometimes, eczema may cause raised bumps that look like pimples or acne. Acne is a skin condition that causes skin breakouts. These may include pimples, blackheads, whiteheads, or nodules.

Eczema coxsackium (EC) is a viral infection that most commonly affects children with atopic dermatitis (a form of eczema). It is sometimes referred to as atypical hand, foot, and mouth disease (HFMD) ...

Is your eczema mild, moderate, or severe? It’s not always an easy question to answer. The seriousness of eczema symptoms can vary a great deal between people. With mild eczema, you may have ...

Dupilumab has been accepted for priority review by the US Food and Drug Administration (FDA) for the treatment of bullous pemphigoid (BP) in adults, according to a press release from the ...

Nemluvio’s approved indications include atopic dermatitis in patients aged 12 years and older and prurigo nodularis in adults. The approvals are supported by two phase 3 clinical trial programs.